PANELS AND TESTS

Easy-to-use. Sample-to-Result. Cost-effective.

Great Basin’s breakthrough approach to molecular diagnostics provides fast, cost-effective diagnosis of infectious diseases.

Our easy-to-use assays deliver more diagnostic data per sample, meaning healthcare providers are able to treat patients with the right medication sooner, improving outcomes and reducing costs.

Stool Bacterial Pathogens Panel

Staph ID/R Blood Culture Panel

Shiga Toxin Direct Test

Bordetella Direct Test

Group B Streptococcus Test

Learn more about how Great Basin’s sample-to-result system can help your hospital or lab make fast and accurate molecular diagnostics possible.

In the News

Great Basin and Rice University Announce Collaboration to Optimize the Design of SARS-CoV-2 Molecular Assays
August 25, 2020

Salt Lake City, Utah, and Houston, Texas – August 25, 2020 (PRWeb) – Great Basin Scientific, a [...]

Vela Diagnostics Submitting Novel Coronavirus Diagnostic Test to FDA for Emergency Use Authorization (UPDATE)
February 11, 2020

Singapore, February 11, 2020 (updated on February 21, 2020) – Vela Diagnostics has developed the [...]

Vela Diagnostics Announces Development of New Test Kit for Detection of Wuhan Coronavirus
January 31, 2020

Singapore, January 30, 2020 – Vela Diagnostics has announced the development of the ViroKeyTM SA201 2019-nCoV [...]

Vela Diagnostics Buys Great Basin Scientific
June 21, 2018

Adds 6 FDA Approved Products on a Medium Multiplexing Platform and Microbiology Know-how Enabling our [...]

Stool Bacterial Pathogens Panel Receives FDA Clearance; Commercial Rollout Begins Immediately
July 13, 2017

At clearance, Company has nearly $2.0 million of potential annual revenue in active or scheduled [...]

Data Demonstrating Efficacy of Stool Bacterial Pathogens Panel Presented at ASM Microbe 2017
June 1, 2017

Four posters describing the Company’s platform to be presented, including a third-party clinical study poster [...]

Bordetella Direct Test Receives FDA Clearance
April 3, 2017

Sample-to-result test for Bordetella pertussis, or whooping cough, receives clearance in fewer than 60 days from [...]

Great Basin Staph ID/R Blood Culture Panel Clinical Evaluation Published in Journal of Clinical Microbiology
February 15, 2017

Multicenter evaluation demonstrates Staph ID/R Blood Culture Panel’s efficacy in rapid identification of Staphylococci and [...]

View More